Which Hedge Funds Own BMY — Bristol Myers Squibb Company

24 of the hedge funds we track hold BMY, worth $3.62B combined as of the Q2 2026 13F filings (preliminary, still landing).

Versus the prior quarter: 1 opened a new position, 8 added, 11 trimmed, 4 exited.

13 of those are hedged quant multi-strategy books, not directional conviction.

Insider buying at BMY · All tracked funds